- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
| home:index [08.03.2017] – [Notes and comments] sallieq | home:index [09.03.2017] – [Notes and comments] sallieq | ||
|---|---|---|---|
| Line 104: | Line 104: | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| + | Sample PubMed cite(({{pubmed> | ||
| + | |||
| + | |||
| + | sample page layout | ||
| + | Symptoms | ||
| + | Management | ||
| + | Recent Research | ||
| + | Evidence of infectious cause | ||
| + | Patient interviews | ||
| + | Patients experiences | ||
| + | References | ||
| + | |||
| + | |||
| --- //Sallie Q 07.09.2017// | --- //Sallie Q 07.09.2017// | ||
| Line 118: | Line 131: | ||
| with bjY08k1ZYvo 'Is there a role for a Tin-Foil hat in PPPM?' presented to the EPMA World Congress : University of Bonn September 2015 | with bjY08k1ZYvo 'Is there a role for a Tin-Foil hat in PPPM?' presented to the EPMA World Congress : University of Bonn September 2015 | ||
| - | TODO replace | + | DONE --- //Sallie Q 08.21.2017// |
| LATER in year with ' Immune Disease and the Microbiome: Healthcare in response to New Knowledge' | LATER in year with ' Immune Disease and the Microbiome: Healthcare in response to New Knowledge' | ||
| Moscow, Russia - September, 2016 | Moscow, Russia - September, 2016 | ||
home/index.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.